cp 93129 has been researched along with ketanserin in 3 studies
| Studies (cp 93129) | Trials (cp 93129) | Recent Studies (post-2010) (cp 93129) | Studies (ketanserin) | Trials (ketanserin) | Recent Studies (post-2010) (ketanserin) |
|---|---|---|---|---|---|
| 109 | 0 | 11 | 3,094 | 335 | 283 |
| Protein | Taxonomy | cp 93129 (IC50) | ketanserin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0016 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0021 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.265 | |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 6.5 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0184 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0027 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.29 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 1.8 | |
| Synaptic vesicular amine transporter | Homo sapiens (human) | 0.18 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banes, AK; Watts, SW | 1 |
| Höglund, AU; Kommalage, M | 1 |
| Jeggo, RD; Jordan, D; Ramage, AG; Wang, Y | 1 |
3 other study(ies) available for cp 93129 and ketanserin
| Article | Year |
|---|---|
Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.
Topics: Animals; Benzamides; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniques; Ketanserin; Male; Mesenteric Arteries; Phenylephrine; Potassium Chloride; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Involvement of spinal serotonin receptors in the regulation of intraspinal acetylcholine release.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Amphetamines; Animals; Biguanides; Citalopram; Dose-Response Relationship, Drug; Ketanserin; Male; Microdialysis; Piperazines; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spinal Cord; Time Factors | 2005 |
Activation of 5-HT1B and 5-HT1D receptors in the rat nucleus tractus solitarius: opposing action on neurones that receive an excitatory vagal C-fibre afferent input.
Topics: Action Potentials; Animals; Benzamides; Drug Synergism; Electric Stimulation; Iontophoresis; Ketanserin; Male; Neural Inhibition; Neurons; Neurons, Afferent; Patch-Clamp Techniques; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Solitary Nucleus; Sumatriptan; Time Factors; Vagus Nerve | 2007 |